RecruitingNCT03460366

Bariatric Surgery and Pharmacokinetics of Enalapril

Bariatric Surgery and Pharmacokinetics Enalapril: BAR-MEDS Enalapril


Sponsor

Norwegian University of Science and Technology

Enrollment

12 participants

Start Date

Nov 2, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

Changes to gastric pH, gastric emptying time, gastrointestinal transit-time or the pre-systemic metabolizing effect of enzymes secreted in the mucosa may all alter the pharmacokinetics of medicines. These factors are potentially influenced by bariatric surgery. Little is so far known about how gastric bypass and sleeve gastrectomy impacts the biological availability of medication. In this study the pharmacokinetic effects of bariatric surgery on enalapril are investigated.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Inclusion Criteria2

  • Preparing to undergo gastric bypass or sleeve gastrectomy in Central Norway
  • Being a Norwegian citizen

Exclusion Criteria1

  • Having previously undergone resections in the GI-tract

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGEnalapril

Patients are tested for their normal prescription enalapril medication


Locations(1)

St. Olavs University Hospital

Trondheim, Norway

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03460366


Related Trials